HK1076625A1 - Derivatives of a-phenylthiocarboxylic and sg(a)-phenyloxy-carboxylic acids useful for the treatment of diseases responding to ppara activation - Google Patents
Derivatives of a-phenylthiocarboxylic and sg(a)-phenyloxy-carboxylic acids useful for the treatment of diseases responding to ppara activationInfo
- Publication number
- HK1076625A1 HK1076625A1 HK05108606.4A HK05108606A HK1076625A1 HK 1076625 A1 HK1076625 A1 HK 1076625A1 HK 05108606 A HK05108606 A HK 05108606A HK 1076625 A1 HK1076625 A1 HK 1076625A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- phenylthiocarboxylic
- phenyloxy
- derivatives
- treatment
- carboxylic acids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/40—Radicals substituted by oxygen atoms
- C07D307/42—Singly bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/708—Ethers
- C07C69/712—Ethers the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/86—Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Furan Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2002RM000014A ITRM20020014A1 (it) | 2002-01-15 | 2002-01-15 | Derivati di acidi a-feniltiocarbossilici e a-fenilossicarbossilici utili per il trattamento di patologie che rispondono all'attivazione del |
| PCT/IT2003/000011 WO2003059875A2 (en) | 2002-01-15 | 2003-01-15 | DERIVATIVES OF α-PHENYLTHIOCARBOXYLIC AND α-PHENYLOXY-CARBOXYLIC ACIDS USEFUL FOR THE TREATMENT OF DISEASES RESPONDING TO PPARα ACTIVATION |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1076625A1 true HK1076625A1 (en) | 2006-01-20 |
Family
ID=11455954
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK05108606.4A HK1076625A1 (en) | 2002-01-15 | 2005-09-29 | Derivatives of a-phenylthiocarboxylic and sg(a)-phenyloxy-carboxylic acids useful for the treatment of diseases responding to ppara activation |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20050054671A1 (xx) |
| EP (1) | EP1474387B1 (xx) |
| JP (1) | JP2005514456A (xx) |
| KR (1) | KR100975961B1 (xx) |
| CN (1) | CN100522940C (xx) |
| AR (1) | AR038146A1 (xx) |
| AT (1) | ATE489361T1 (xx) |
| AU (1) | AU2003209679B2 (xx) |
| BR (1) | BR0306824A (xx) |
| CA (1) | CA2472223A1 (xx) |
| DE (1) | DE60335083D1 (xx) |
| HK (1) | HK1076625A1 (xx) |
| IT (1) | ITRM20020014A1 (xx) |
| MX (1) | MXPA04006803A (xx) |
| PL (1) | PL372666A1 (xx) |
| TW (1) | TW200305410A (xx) |
| WO (1) | WO2003059875A2 (xx) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004022551A1 (ja) * | 2002-09-06 | 2004-03-18 | Takeda Pharmaceutical Company Limited | フランまたはチオフェン誘導体およびその医薬用途 |
| ITRM20020629A1 (it) * | 2002-12-19 | 2004-06-20 | Sigma Tau Ind Farmaceuti | Uso di acidi alfa-feniltiocarbossilici e alfa-fenilossicarbossilici ad attivita' ipoglicemizzante e/o ipolipidemizzante. |
| PT1667964E (pt) | 2003-09-19 | 2009-09-02 | Janssen Pharmaceutica Nv | Ácidos 4-((fenoxialquil)tio)-fenoxiacéticos e análogos |
| RU2006112342A (ru) * | 2003-10-28 | 2007-12-10 | Д-р Редди`с Лабораторис Лтд (IN) | Новые соединения и их использование в медицине, способ их получения и содержащие их фармацетические композиции |
| US7902367B2 (en) * | 2004-08-11 | 2011-03-08 | Kyorin Pharmaceutical Co., Ltd. | Cyclic amino benzoic acid derivative |
| MY147518A (en) | 2004-09-15 | 2012-12-31 | Janssen Pharmaceutica Nv | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| FR2880886B1 (fr) * | 2005-01-14 | 2007-04-06 | Merck Sante Soc Par Actions Si | Derives de l'acide 6-phenylhex-5-enoique, procedes pour leur preparation, compositions pharmaceutiques les contenant et applications en therapeutique |
| WO2006082495A1 (en) * | 2005-02-02 | 2006-08-10 | Ranbaxy Laboratories Limited | Peroxisome proliferator activated receptor modulators |
| FR2882359A1 (fr) * | 2005-02-24 | 2006-08-25 | Negma Lerads Soc Par Actions S | Derives activateurs de ppar, procede de preparation et application en therapeutique |
| EP1862464A4 (en) * | 2005-03-23 | 2010-08-25 | Kyorin Seiyaku Kk | NEW CYCLIC AMINOPHENYL ALKANIC ACID DERIVATIVE |
| JO3006B1 (ar) | 2005-09-14 | 2016-09-05 | Janssen Pharmaceutica Nv | املاح ليسين مبتكرة من مشتقات حامض 4-((فينوكسي الكيل)ثيو) فينوكسي الخليك |
| UY30288A1 (es) | 2006-04-18 | 2007-08-31 | Janssen Pharmaceutica Nv | Derivados del ácido benzoazepin-oxi-acético como agonistas de ppar-delta usados para aumentar hdl-c. reducir ldl-c y reducir colesterol |
| CA2672267C (en) * | 2006-07-27 | 2016-05-31 | Emisphere Technologies, Inc. | Arylsulfanyl compounds and compositions for delivering active agents |
| JP5305818B2 (ja) * | 2008-10-03 | 2013-10-02 | キヤノン株式会社 | 生体情報取得装置 |
| JP5669889B2 (ja) * | 2013-06-27 | 2015-02-18 | キヤノン株式会社 | 生体情報取得装置 |
| CN106179111B (zh) * | 2016-07-16 | 2018-08-14 | 江南大学 | 一种由羧酸盐阴离子表面活性剂和二聚季铵盐形成的粘弹溶液 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1121722A (en) * | 1966-03-31 | 1968-07-31 | Ici Ltd | New carboxylic acid derivatives |
| US3663540A (en) * | 1970-06-19 | 1972-05-16 | R & L Molecular Research Ltd | 7 - (p-aminomethylphenylthio)acetamido-3 -(pyridiniummethyl)ceph - 3 - em - 4-carboxylate |
| US3965093A (en) * | 1971-09-24 | 1976-06-22 | E. R. Squibb & Sons, Inc. | 6-Arylthio penicillanic acid and derivatives thereof |
| GB1422679A (en) * | 1972-11-16 | 1976-01-28 | Funai Pharmaceutical Ind Ltd | Substituted phenoxy-a-methylpropionic acid derivatives and a process for producing the same |
| FR2285859A1 (fr) * | 1974-09-30 | 1976-04-23 | Lafon Labor | Phenylsulfinyl-amidines et derives |
| DE2861187D1 (en) * | 1977-07-07 | 1981-12-24 | Ciba Geigy Ag | Phenoxy-phenylsulfinyl-and-sulfonylalkanecarboxylic acid derivatives, method for their preparation and their use as herbicides and plant growth regulators. |
| JPH0311045A (ja) * | 1989-06-08 | 1991-01-18 | Hodogaya Chem Co Ltd | ベンズアミド誘導体 |
| JPH06234732A (ja) * | 1992-09-10 | 1994-08-23 | Banyu Pharmaceut Co Ltd | 置換アセトアミド誘導体 |
| FR2700166B1 (fr) * | 1993-01-07 | 1995-02-17 | Rhone Poulenc Rorer Sa | Dérivés de pyrrolidine, leur préparation et les médicaments les contenant. |
| JP3583529B2 (ja) * | 1995-12-04 | 2004-11-04 | 富士写真フイルム株式会社 | ハロゲン化銀感光材料 |
| ATE262334T1 (de) * | 1996-02-02 | 2004-04-15 | Merck & Co Inc | Antidiabetisches mittel |
| AU4050797A (en) | 1996-08-02 | 1998-02-25 | Ligand Pharmaceuticals Incorporated | Prevention or treatment of type 2 diabetes or cardiovascular disease with ppar modulators |
| US6197791B1 (en) * | 1997-02-27 | 2001-03-06 | American Cyanamid Company | N-hdroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| US6294573B1 (en) * | 1997-08-06 | 2001-09-25 | Abbott Laboratories | Reverse hydroxamate inhibitors of matrix metalloproteinases |
| JP4033630B2 (ja) * | 1998-06-22 | 2008-01-16 | バジリア ファルマスーチカ アーゲー | プロペニルセファロスポリン誘導体 |
| JP4618845B2 (ja) * | 1999-06-09 | 2011-01-26 | 杏林製薬株式会社 | ヒトペルオキシゾーム増殖薬活性化受容体（ＰＰＡＲ）αアゴニストとしての置換フェニルプロピオン酸誘導体 |
| DE19940415A1 (de) * | 1999-08-26 | 2001-03-08 | Friedrich Spener | Verzweigtkettige Fettsäuren als fettabbauende Wirkstoffe |
| US6525093B1 (en) * | 1999-11-08 | 2003-02-25 | Calyx Therapeutics Inc. | Compounds to treat diabetes and associated conditions |
| MXPA02007295A (es) * | 2000-01-28 | 2002-11-29 | Novo Nordisk As | Derivados de acido propionico alquinilsubstituidos y su uso contra diabetes y obesidad. |
| WO2001079150A1 (en) * | 2000-04-17 | 2001-10-25 | Novo Nordisk A/S | New compounds, their preparation and use |
| ATE407919T1 (de) * | 2000-05-29 | 2008-09-15 | Kyorin Seiyaku Kk | Substituierte phenylpropionsäure-derivate |
| DE60129712T2 (de) * | 2000-08-23 | 2008-07-03 | Eli Lilly And Co., Indianapolis | Oxazolylaryloxyessigsäure derivate und ihre verwendung als ppar agonisten |
| GB0111523D0 (en) * | 2001-05-11 | 2001-07-04 | Glaxo Group Ltd | Chemical compounds |
-
2002
- 2002-01-15 IT IT2002RM000014A patent/ITRM20020014A1/it unknown
-
2003
- 2003-01-15 MX MXPA04006803A patent/MXPA04006803A/es active IP Right Grant
- 2003-01-15 TW TW092101061A patent/TW200305410A/zh unknown
- 2003-01-15 WO PCT/IT2003/000011 patent/WO2003059875A2/en active Application Filing
- 2003-01-15 AU AU2003209679A patent/AU2003209679B2/en not_active Ceased
- 2003-01-15 PL PL03372666A patent/PL372666A1/xx unknown
- 2003-01-15 BR BR0306824-2A patent/BR0306824A/pt not_active IP Right Cessation
- 2003-01-15 DE DE60335083T patent/DE60335083D1/de not_active Expired - Lifetime
- 2003-01-15 KR KR1020047010634A patent/KR100975961B1/ko not_active IP Right Cessation
- 2003-01-15 EP EP03729547A patent/EP1474387B1/en not_active Expired - Lifetime
- 2003-01-15 AR ARP030100103A patent/AR038146A1/es unknown
- 2003-01-15 US US10/501,472 patent/US20050054671A1/en not_active Abandoned
- 2003-01-15 CN CNB038022893A patent/CN100522940C/zh not_active Expired - Fee Related
- 2003-01-15 JP JP2003559979A patent/JP2005514456A/ja active Pending
- 2003-01-15 AT AT03729547T patent/ATE489361T1/de not_active IP Right Cessation
- 2003-01-15 CA CA002472223A patent/CA2472223A1/en not_active Abandoned
-
2005
- 2005-09-29 HK HK05108606.4A patent/HK1076625A1/xx not_active IP Right Cessation
-
2007
- 2007-08-17 US US11/889,930 patent/US20080027098A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003209679B2 (en) | 2009-02-19 |
| CN1620429A (zh) | 2005-05-25 |
| WO2003059875A2 (en) | 2003-07-24 |
| CN100522940C (zh) | 2009-08-05 |
| WO2003059875A3 (en) | 2003-12-04 |
| KR100975961B1 (ko) | 2010-08-16 |
| EP1474387A2 (en) | 2004-11-10 |
| JP2005514456A (ja) | 2005-05-19 |
| ATE489361T1 (de) | 2010-12-15 |
| US20080027098A1 (en) | 2008-01-31 |
| US20050054671A1 (en) | 2005-03-10 |
| MXPA04006803A (es) | 2004-10-11 |
| BR0306824A (pt) | 2004-12-21 |
| TW200305410A (en) | 2003-11-01 |
| DE60335083D1 (de) | 2011-01-05 |
| EP1474387B1 (en) | 2010-11-24 |
| AR038146A1 (es) | 2004-12-29 |
| ITRM20020014A1 (it) | 2003-07-15 |
| KR20040068996A (ko) | 2004-08-02 |
| AU2003209679A1 (en) | 2003-07-30 |
| CA2472223A1 (en) | 2003-07-24 |
| ITRM20020014A0 (it) | 2002-01-15 |
| PL372666A1 (en) | 2005-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1076625A1 (en) | Derivatives of a-phenylthiocarboxylic and sg(a)-phenyloxy-carboxylic acids useful for the treatment of diseases responding to ppara activation | |
| AU2003291992A1 (en) | Phenylethanolamine derivatives for the treatment of respiratory diseases | |
| AU2003270903A8 (en) | A video game for assisting healing of the human body | |
| AU2003279338A1 (en) | Phenethanolamine derivatives for the treatment of respiratory diseases | |
| IL166150A0 (en) | Apparatus for altering the body temperature of a patient | |
| PL377122A1 (pl) | Pochodne fenetanoloaminy do leczenia chorób układu oddechowego | |
| AU2003210428A1 (en) | Phenethanolamine derivatives for treatment of respiratory diseases | |
| AU2003301347A1 (en) | Methods for monitoring treatment of disease | |
| EP1571970A3 (en) | Diagnosis and monitoring of diseases | |
| DE60322451D1 (de) | 4-Tetrazolyl-4-Phenylpiperidinderivate zur Schmerzbehandlung | |
| PL375964A1 (en) | Use of indolyl derivatives for the manufacture of a medicament for the treatment allergic rhinitis | |
| AU2003279442A8 (en) | 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes | |
| PL372695A1 (en) | Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins | |
| PT1487828E (pt) | Derivados de morfolinil-ureia para utilização no tratamento de doenças inflamatórias | |
| IL166016A0 (en) | Topical treatment of skin diseases | |
| AU2003267532A1 (en) | PEPTIDES AND PEPTIDE DERIVATIVES FOR THE TREATMENT OF Alpha-SYNUCLEIN-RELATED DISEASES | |
| AU2003232148A1 (en) | A selective inos inhibitor and a pde inhibitor in combination for the treatment of respiratory diseases | |
| HK1074402A1 (en) | Use of amide derivative of ge 2270 factor a3 for the treatment of acne | |
| AU2003285946A8 (en) | Identification of antimycobacterial targets and the inhibition thereof as a treatment for infectious diseases | |
| EP1577290A4 (en) | AMID CONNECTION AND METHOD FOR COMBATING PLANT DISEASES THEREFOR | |
| AU2003201630A1 (en) | A method for the diagnosis of lymphoproliferative diseases | |
| IL164826A0 (en) | Methods for the treatment of respiratory diseases and conditions using a selective inos inhibitor | |
| AU2003288557A1 (en) | Improvements in or relating to sensor devices for monitoring the condition of a human or animal patient | |
| AU2003297570A1 (en) | Treatment of skin diseases | |
| AU2003269824A1 (en) | Method for determining the state of the surface of the skin of a human or animal body and arrangement for carrying out said method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20140115 |